EcoR1 discloses Atara stake in Form 3
EcoR1 Capital, LLC filed an initial Form 3 reporting its status as a more than ten percent owner of Atara Biotherapeutics, Inc. common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
EcoR1 Capital, LLC filed an initial Form 3 reporting its status as a more than ten percent owner of Atara Biotherapeutics, Inc. common stock. The filing shows indirect beneficial ownership of 1,044,593 shares, with EcoR1-related Qualified Fund holding 970,829 shares for the benefit of its investors.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Common Stock | -- | -- | -- |
Footnotes (2)
- F1. The reporting persons are EcoR1 Capital, LLC ("EcoR1"), EcoR1 Capital Fund Qualified L.P. ("Qualified Fund") and Oleg Nodelman. EcoR1 is the general partner and investment adviser of private funds, including Qualified Fund (the "Funds"). Mr. Nodelman is the manager and controlling owner of EcoR1. EcoR1 is filing this Form 3 for itself, Mr. Nodelman and Qualified Fund. The reporting persons are filing this Form 3 jointly, but not as a group, and each expressly disclaims membership in a group within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934. The Funds hold these securities directly for the benefit of their investors. EcoR1 may be deemed to indirectly beneficially own them as the investment adviser to the Funds. Mr. Nodelman may be deemed to indirectly beneficially own them as the control person of EcoR1. The reporting persons disclaim beneficial ownership of such securities except to the extent of their respective pecuniary interests therein.
- F2. Qualified Fund beneficially owns 970,829 shares of Common Stock.
Key Figures
Key Terms
ten percent owner regulatory
beneficial ownership financial
pecuniary interests financial
Rule 13d-5(b) regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does EcoR1 Capital report in its Atara (ATRA) Form 3 filing?
Is EcoR1 Capital a ten percent owner of Atara Biotherapeutics (ATRA)?
Does the EcoR1 Capital Form 3 for Atara (ATRA) show any recent buy or sell transactions?
AI-generated analysis. How Rhea-AI works. Not financial advice.